Positive Results!, page-92

First 92 Last

Share
Profile

Follow
prodigy1

1,222 Posts.

158

07/12/21

13:28

Post #: 58129296
Share

Originally posted by Mbox: ↑

Another of the long-term term rusted-on shareholders here. Beyond delighted to get to this point, which has taken far, far longer than I'd ever anticipated. Over the moon for the Rhett families.... now so much more than just hope for them.

My biggest concern now is NEU and its long-suffering shareholders (long-suffering by choice admittedly) not getting the opportunity to capitalise on this milestone and the pathway ahead. As John said in the presentation this morning, today is really just the start for NEU.

In my completely uneducated opinion this has got to have at least $20/share written on it. The last thing I want at this stage is Arcadia/Baker Bros or someone else lobbing in a takeover offer of say $6-$7 and to have NEU disappear.

If I was working for Arcadia, I'd be looking at the options of simply sitting tight and coughing up AUD110 over 2022-2023 as per John's presentation and then further sales milestones (another $300m?) and double digit royalties for the life of Trof vs taking the entire company, now still only worth AUD219. That includes the worldwide rights for Trof, all the promise of a superior drug that can treat a wider range of conditions (NNZ2591) and the rest, including the yet unproven but occasionally touted 'aspirin for the brain' potential, and perhaps another run at TBI with all the knowledge we now have on dosing regimes. Be nuts not to make a tilt at that, even if you had to pay AUD400-500m. I think there's a serious risk of that outcome unfortunately. If not Arcadia, someone else....

Here's hoping we're all still here to celebrate next Christmas as NEU shareholders with a bunch of positive results in the Phase 2 trials for NNZ2591.

Congratulations to all LT shareholders.....a win for the little guys indeed!

Expand

I agree with the $20. This was my target from day dot, rightly or wrongly.

John has reiterated though, they are looking at all options at maximising shareholder value and not necessarily the quickest way out. At this stage, I am comfortable that they are not looking to sell (or give it away) for anything near the $6-$7 range.

Have not sold a share from day one and still not selling anything anytime soon.

NEU Price at posting: $3.43 Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply

Top Stories

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

There are more pages in this discussion • 75 more messages in this thread...

First 92 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $12.35		Change 0.070(0.57%)		Mkt cap ! $1.578B

Open	High	Low	Value	Volume
$12.25	$12.45	$12.02	$7.808M	638.6K

Buyers (Bids)

No.	Vol.	Price($)
1	41	$12.35

Sellers (Offers)

Price($)	Vol.	No.
$12.37	1579	2

View Market Depth

No.	Vol.	Price($)
1	41	12.350
1	40	12.300
1	1854	12.270
1	50	12.250
2	6431	12.240

Price($)	Vol.	No.
12.370	1579	2
12.380	1473	1
12.450	1300	1
12.490	678	1
12.500	1184	2

Last trade - 16.10pm 31/10/2024 (20 minute delay)

NEU (ASX) Chart

Positive Results!, page-92

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Positive Results!, page-92

Top Stories

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News